Prognostic significance of morphometric parameters of nucleoli and nuclei of invasive ductal breast carcinomas

Polish Journal of Pathology

Volumn 60, Issue 3, 2009, Pages 124-129

  Karpińska Kaczmarczyk, Katarzyna ^a   Kram, Andrzej ^a   Kaczmarczyk, Mariusz ^a   Domagala, Wenancjusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Breast carcinoma; Morphometry; Nucleolus; Nucleus; Prognosis

Indexed keywords

ARTICLE; BREAST TUMOR; CELL NUCLEUS; FEMALE; FOLLOW UP; HUMAN; IMAGE PROCESSING; KAPLAN MEIER METHOD; NUCLEOLUS; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL NUCLEOLUS; CELL NUCLEUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KAPLAN-MEIERS ESTIMATE; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 77951630041     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Derenzini M, Treré D, Pession A, et al. Nucleolar function and size in cancer cells. Am J Pathol 1998; 152: 1291-1297.
2. Derenzini M, Treré D, Pession A, et al. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol 2000; 191: 181-186.
3. Derenzini M, Montanaro L, Treré D. What the nucleolus says to a tumour pathologist. Histopathology 2009; 54: 753-762.
4. Maggi LB, Weber JD. Nucleolar adaptation in human cancer. Cancer Invest 2005; 23: 599-608.
5. Treré D, Ceccarelli C, Montanaro L, et al. Nucleolar size and activity are related to pRb and p53 status in human breast cancer. J Histochem Cytochem 2004; 52: 1601-1607.
6. Maset RS, DePinho RA. Keeping telomerase in its place. Nat Med 2002; 8: 934-936.
7. Olson MO, Hingorani K, Szebeni A. Conventional and nonconventional roles of the nucleolus. Int Rev Cytol 2002; 219: 199-266.
8. Vega LR, Mateyak MK, Zakian VA. Getting to the end: telomerase access in yeast and humans. Nat Rev Mol Cell Biol 2003; 4: 948-959.
9. Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 2003; 22: 6068-6077.
10. Hernandez-Verdun D. Nucleolus: from structure to dynamics. Histochem CeU Biol 2006; 125: 127-137.
11. Ploton D, Menaget M, Jeannesson P, et al. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem J 1986; 18: 5-14.
12. Vacca LL. Laboratory Manual of Histochemistry. Raven Press, New York 1985.
13. Pich A, Chiusa L, Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron 2000; 31: 133-141.
14. Derenzini M, Treré D, O'Donohue MF, et al. Interphase nucleolar organizer regions in tumor pathology. In: Molecular biology in cellular pathology. Crocker J, Murray PG (eds.). Wiley, Chichester 2003; 137-152.
15. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
16. Baak JP. The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer. Histopathology 1985; 9: 437-444.
17. van der Linden HC, Baak JP, Lindeman J, et al. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results. J Clin Pathol 1986; 39: 603-609.
18. Baak JP, Van Dop H, Kurver PH, et al. The value of morphometry to classic prognosticators in breast cancer. Cancer 1985; 56: 374-382.
19. Baak JP, Kurver PH, De Snoo-Niewlaat AJ, et al. Prognostic indicators in breast cancer - morphometric methods. Histopathology 1982; 6: 327-339.
20. van Diest PJ, Mouriquand J, Schipper NW, et al. Prognostic value of nucleolar morphometric variables in cytological breast cancer specimens. J Clin Pathol 1990; 43: 157-159.
21. Zajdela A, de LaRiva LS, Ghossein NA. The relation of prognosis to the nuclear diameter of breast cancer cells obtained by cytologic aspiration. Acta Cytol 1979; 23: 75-80.
22. van Bogaert LJ, de Muylder C, Maldague P, et al. Prognostic implications of mean nuclear diameter in breast cancer. Br J Cancer 1980; 42: 537-541.
23. Lloreta J, Ferre MD, Corominas JM, et al. Prediction of recurrence and nucleolar features in node-negative breast carcinoma, ductal type, grade II. An ultrastructural study. Virchows Arch 2002; 440: 280-284.
24. Pienta KJ, Coffey DS. Correlation of nuclear morphometry with progression of breast cancer. Cancer 1991; 68: 2012-2016.
25. Sacks NP, Robertson JF, Ellis IO, et al. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer. Eur J Surg Oncol 1992; 18: 98-102.
26. Toikkanen S, Joensuu H. AgNOR counts have no prognostic value in breast cancer. J Pathol 1993; 169: 251-254.
27. Lipponen P, Aaltomaa S, Syrjänen K. Morphometric quantitation of nucleolar organizer region proteins in breast carcinoma. Anal Quant Cytol Histol 1993; 15: 311-316.